Gabelli Funds LLC boosted its holdings in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 223.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 218,500 shares of the medical device company’s stock after purchasing an additional 150,880 shares during the quarter. Gabelli Funds LLC owned approximately 0.66% of Cardiovascular Systems worth $6,151,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of the business. BNP Paribas Arbitrage SA boosted its position in shares of Cardiovascular Systems by 160.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 5,135 shares of the medical device company’s stock valued at $166,000 after acquiring an additional 3,165 shares during the last quarter. BlueCrest Capital Management Ltd bought a new position in shares of Cardiovascular Systems during the 2nd quarter valued at approximately $204,000. Winslow Evans & Crocker Inc. boosted its position in shares of Cardiovascular Systems by 21.3% during the 2nd quarter. Winslow Evans & Crocker Inc. now owns 6,550 shares of the medical device company’s stock valued at $210,000 after acquiring an additional 1,150 shares during the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Cardiovascular Systems by 809.3% during the 1st quarter. UBS Asset Management Americas Inc. now owns 8,393 shares of the medical device company’s stock valued at $237,000 after acquiring an additional 7,470 shares during the last quarter. Finally, Legal & General Group Plc boosted its position in shares of Cardiovascular Systems by 2.9% during the 2nd quarter. Legal & General Group Plc now owns 7,763 shares of the medical device company’s stock valued at $249,000 after acquiring an additional 216 shares during the last quarter. Institutional investors and hedge funds own 72.09% of the company’s stock.
In related news, CEO Scott R. Ward sold 5,529 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $30.41, for a total transaction of $168,136.89. Following the sale, the chief executive officer now owns 282,536 shares in the company, valued at approximately $8,591,919.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Laurence L. Betterley sold 4,443 shares of the stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $30.74, for a total value of $136,577.82. Following the sale, the chief financial officer now owns 223,557 shares in the company, valued at approximately $6,872,142.18. The disclosure for this sale can be found here. Insiders have sold a total of 51,065 shares of company stock worth $1,514,031 in the last 90 days. 3.30% of the stock is currently owned by insiders.
Shares of Cardiovascular Systems, Inc. (NASDAQ CSII) opened at $23.73 on Monday. Cardiovascular Systems, Inc. has a twelve month low of $23.00 and a twelve month high of $33.11. The firm has a market capitalization of $809.70, a price-to-earnings ratio of 1,186.50 and a beta of 2.53. The company has a current ratio of 4.30, a quick ratio of 3.83 and a debt-to-equity ratio of 0.18.
Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings results on Wednesday, October 25th. The medical device company reported ($0.06) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The company had revenue of $49.70 million for the quarter, compared to analyst estimates of $51.00 million. During the same quarter in the prior year, the firm posted ($0.06) EPS. Cardiovascular Systems’s quarterly revenue was down .2% compared to the same quarter last year. equities analysts forecast that Cardiovascular Systems, Inc. will post -0.05 earnings per share for the current fiscal year.
A number of research analysts have recently commented on CSII shares. Citigroup Inc. started coverage on Cardiovascular Systems in a research report on Thursday, September 21st. They set a “market perform” rating for the company. Needham & Company LLC reiterated a “buy” rating and set a $37.00 target price on shares of Cardiovascular Systems in a research report on Thursday, October 12th. Zacks Investment Research downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a research report on Tuesday, October 10th. Raymond James Financial, Inc. started coverage on Cardiovascular Systems in a research report on Friday, September 22nd. They set a “market perform” rating for the company. Finally, BidaskClub downgraded Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a research report on Friday, August 18th. Three analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $35.33.
ILLEGAL ACTIVITY WARNING: This piece was reported by Markets Daily and is owned by of Markets Daily. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.themarketsdaily.com/2017/11/13/cardiovascular-systems-inc-csii-holdings-lifted-by-gabelli-funds-llc.html.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).
Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.